CATALYST PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Del Carmen Jeffrey | Chief Commercial Officer | Option Exercise | 10,667 | — | — | 33,548 | Feb 14, 2025 |
| Miller Steve | Chief Op. & Scientific Officer | Option Exercise | 13,667 | — | — | 949,663 | Feb 14, 2025 |
| Elsbernd Brian | Chief Compliance/Legal Officer | Option Exercise | 9,667 | — | — | 190,917 | Feb 14, 2025 |
| Sundaram Preethi | Chief Strategy Officer | Option Exercise | 16,667 | — | — | 50,970 | Feb 14, 2025 |
| Harper Molly | — | Option Exercise | 4,000 | — | — | 6,746 | Feb 14, 2025 |
| DENKHAUS DONALD A | — | Option Exercise | 50,000 | $2.24 | $112,000 | 491,079 | Jan 8, 2025 |
| Kalb Michael Wayne | Executive Vice President & CFO | Tax Withholding | 2,941 | — | — | 4,197 | Jan 2, 2025 |
| Daly Richard J | President and CEO | Option Exercise | 42,105 | — | — | 277,938 | Jan 2, 2025 |
| O'Keeffe Charles B | — | Option Exercise | 1,333 | — | — | 728,470 | Dec 27, 2024 |
| Del Carmen Jeffrey | Chief Commercial Officer | Option Exercise | 8,667 | — | — | 26,720 | Dec 27, 2024 |
| Sundaram Preethi | Chief Strategy Officer | Option Exercise | 6,667 | — | — | 36,648 | Dec 27, 2024 |
| Miller Steve | Chief Op. & Scientific Officer | Option Exercise | 14,000 | — | — | 935,996 | Dec 27, 2024 |
| Harper Molly | — | Option Exercise | 1,333 | — | — | 2,746 | Dec 27, 2024 |
| DENKHAUS DONALD A | — | Option Exercise | 1,333 | — | — | 441,079 | Dec 27, 2024 |
| Tierney David S | — | Option Exercise | 1,333 | — | — | 351,620 | Dec 27, 2024 |
| Elsbernd Brian | Chief Compliance/Legal Officer | Option Exercise | 6,667 | — | — | 183,191 | Dec 27, 2024 |
| Daly Richard J | President and CEO | Option Exercise | 1,333 | — | — | 236,157 | Dec 27, 2024 |
| INGENITO GARY | Chief Med. & Reg. Officer | Tax Withholding | 3,541 | — | — | 61,308 | Dec 27, 2024 |
| Miller Steve | Chief Op. & Scientific Officer | Option Exercise | 235,000 | $4.01 | $942,350 | 921,996 | Dec 13, 2024 |
| Miller Steve | Chief Op. & Scientific Officer | Option Exercise | 11,872 | — | — | 686,996 | Dec 10, 2024 |
| Harper Molly | — | Option Exercise | 1,413 | — | — | 1,413 | Dec 9, 2024 |
| O'Keeffe Charles B | — | Option Exercise | 40,000 | $4.01 | $160,400 | 727,137 | Dec 9, 2024 |
| Sundaram Preethi | Chief Strategy Officer | Tax Withholding | 2,415 | — | — | 29,981 | Dec 9, 2024 |
| Elsbernd Brian | Chief Compliance/Legal Officer | Tax Withholding | 1,720 | — | — | 176,524 | Dec 9, 2024 |
| Del Carmen Jeffrey | Chief Commercial Officer | Tax Withholding | 2,355 | — | — | 18,053 | Dec 9, 2024 |
| Tierney David S | — | Option Exercise | 1,413 | — | — | 350,287 | Dec 9, 2024 |
| INGENITO GARY | Chief Med. & Reg. Officer | Option Exercise | 7,349 | — | — | 58,740 | Dec 9, 2024 |
| MCENANY PATRICK J | — | Option Exercise | 3,533 | — | — | 4,481,702 | Dec 9, 2024 |
| DENKHAUS DONALD A | — | Option Exercise | 1,413 | — | — | 439,746 | Dec 9, 2024 |
| Thompson Tamar | — | Option Exercise | 1,413 | — | — | 1,413 | Dec 9, 2024 |
| INGENITO GARY | Chief Med. & Reg. Officer | Sale | 8,631 | $22.74 | $196,269 | 54,760 | Nov 27, 2024 |
| Harper Molly | — | Option Exercise | 17,500 | $5.78 | $101,150 | 17,500 | Nov 27, 2024 |
| Elsbernd Brian | Chief Compliance/Legal Officer | Sale | 3,956 | $21.58 | $85,370 | 171,177 | Nov 26, 2024 |
| INGENITO GARY | Chief Med. & Reg. Officer | Option Exercise | 38,000 | $4.01 | $152,380 | 89,391 | Nov 20, 2024 |
| MCENANY PATRICK J | — | Option Exercise | 72,500 | $3.54 | $256,650 | 4,550,669 | Nov 19, 2024 |
| MCENANY PATRICK J | — | Option Exercise | 92,500 | $3.54 | $327,450 | 4,570,669 | Nov 13, 2024 |
| MCENANY PATRICK J | — | Option Exercise | 70,000 | $4.01 | $280,700 | 4,548,169 | Nov 11, 2024 |
| MCENANY PATRICK J | — | Gift | 5,100 | — | — | 4,478,169 | Aug 22, 2024 |
| Tierney David S | — | Option Exercise | 15,000 | $4.01 | $60,150 | 363,874 | Aug 21, 2024 |
| Miller Steve | Chief Op. & Scientific Officer | Sale | 50,000 | $20.21 | $1,010,500 | 725,124 | Aug 20, 2024 |
| MCENANY PATRICK J | — | Gift | 45,000 | — | — | 4,483,269 | Aug 15, 2024 |
| Del Carmen Jeffrey | Chief Commercial Officer | Option Exercise | 30,000 | $2.86 | $85,800 | 42,369 | Aug 9, 2024 |
| INGENITO GARY | Chief Med. & Reg. Officer | Option Exercise | 100,000 | $4.01 | $401,000 | 151,391 | Aug 9, 2024 |
| Del Carmen Jeffrey | Chief Commercial Officer | Sale | 7,541 | $16.07 | $121,184 | 18,427 | Jun 7, 2024 |
| INGENITO GARY | Chief Med. & Reg. Officer | Option Exercise | 80,000 | $4.01 | $320,800 | 131,391 | Jun 5, 2024 |
| Daly Richard J | President and CEO | Sale | 17,323 | $15.98 | $276,822 | 234,824 | Jun 4, 2024 |
| Harper Molly | — | Sale | 5,333 | $16.30 | $86,928 | — | Jun 3, 2024 |
| Tierney David S | — | Option Exercise | 25,000 | $4.01 | $100,250 | 373,874 | Apr 8, 2024 |
| Elsbernd Brian | Chief Compliance/Legal Officer | Sale | 25,000 | $16.44 | $411,000 | 124,433 | Mar 27, 2024 |
| Tierney David S | — | Option Exercise | 4,000 | — | — | 348,874 | Feb 15, 2024 |